SignatureFD’s Abeona Therapeutics ABEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.95K Buy
+372
New +$2.31K ﹤0.01% 3202
2025
Q4
– Sell
-687
Closed -$3.63K – 3406
2025
Q3
$3.63K Buy
687
+512
+293% +$3.25K ﹤0.01% 2779
2025
Q2
$994 Buy
+175
New +$996 ﹤0.01% 3026
2020
Q2
– Hold
0
– – – 2472
2020
Q1
– Hold
0
– – – 2270
2019
Q4
– Hold
0
– – – 2171
2019
Q3
– Hold
0
– – – 2084
2019
Q2
– Hold
0
– – – 2016
2019
Q1
– Hold
0
– – – 1953
2018
Q4
– Hold
0
– – – 1922
2018
Q3
– Hold
0
– – – 1899
2018
Q2
– Hold
0
– – – 1899
2018
Q1
– Hold
0
– – – 1732

Other funds holding ABEO

SignatureFD's ABEO Position: Q3 2026 in Review

SignatureFD opened a new position in Abeona Therapeutics (ABEO) in Q3 2026: 372 shares worth $1.95K. The stake represents ﹤0.01% of the portfolio and ranks #3202 among its holdings. This is a return to the name: SignatureFD previously reported a position in ABEO as recently as Q3 2025.

SignatureFD first reported a position in ABEO in Q2 2025 and has held it in 3 quarters since. The position peaked at $3.63K in Q3 2025. 110 funds tracked by Wall St. Rank hold ABEO as of Q3 2026.

  • SignatureFD held 372 shares of Abeona Therapeutics worth $1.95K as of Q3 2026.
  • Abeona Therapeutics was a new SignatureFD position in Q3 2026.
  • Abeona Therapeutics made up ﹤0.01% of SignatureFD's portfolio in Q3 2026, its #3202 holding.
  • SignatureFD first reported a position in Abeona Therapeutics in Q2 2025 and has held it in 3 quarters since.
  • SignatureFD's Abeona Therapeutics position peaked at $3.63K in Q3 2025.
  • 110 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q3 2026.

Based on SignatureFD's 13F filing for Q3 2026, filed 23 Oct 2026.